【摘 要】
：
We conducted a randomized,open-label,parallel-controlled,multicenter trial on the use of Shuanghuanglian(SHL),a traditional Chinese patent medicine,in treating cases of COVID-19.A total of 176 patients received SHL by three doses(56 in low dose,61 in midd
【机 构】
：
Division of Cardiology,Department of Internal Medicine and Hubei Key Laboratory of Genetics and Mole
论文部分内容阅读
We conducted a randomized,open-label,parallel-controlled,multicenter trial on the use of Shuanghuanglian(SHL),a traditional Chinese patent medicine,in treating cases of COVID-19.A total of 176 patients received SHL by three doses(56 in low dose,61 in middle dose,and 59 in high dose)in addition to standard care.The control group was composed of 59 patients who received standard therapy alone.Treatment with SHL was not associated with a difference from standard care in the time to disease recovery.Patients with 14-day SHL treatment had significantly higher rate in negative conversion of SARS-CoV-2 in nucleic acid swab tests than the patients from the control group(93.4％vs.73.9％,P=0.006).Analysis of chest computed tomography images showed that treatment with high-dose SHL significantly promoted absorption of inflammatory focus of pneumonia,which was evaluated by density reduction of inflammatory focus from baseline,at day 7(mean difference(95％CI),-46.39(-86.83 to-5.94)HU;P=0.025)and day 14(mean difference(95％CI),-74.21(-133.35 to-15.08)HU;P=0.014).No serious adverse events occurred in the SHL groups.This study illustrated that SHL in combination with standard care was safe and partially effective for the treatment of COVID-19.
其他文献
Relapse is the main problem after allogeneic hematopoietic stem cell transplantation(allo-HSCT).The outcome of a second allo-HSCT(HSCT2)for relapse post-HSCT has shown promising results in some previous studies.However,little is known about the efficacy o
黏细菌是天然产物的重要来源.纤维堆囊菌So0157-2是抗癌药物埃博霉素的产生菌,并且是已知基因组最大的原核生物.生物信息学分析发现该菌一共含有35个次级代谢产物生物合成基因簇,除了已知的埃博霉素基因簇和其他两个萜类化合物生物合成基因簇与已知基因簇的相似度为100％之外,其他基因簇与已知化合物基因簇相似度均较低,其中包括17个聚酮合酶(polyketide synthase,PKS)、非核糖体肽合成酶(nonribosomal peptide synthetase,NRPS)及其杂合的基因簇.由于纤维堆囊
Protein XPA plays critical roles in nucleotide excision repair pathway.Recent experimental work showed that the functional dynamics of XPA involves the one-dimensional diffusion along DNA to search the damage site.Here,we inves-tigate the involved dynamic
This paper presents a theoretical model for predicting and tuning magnetoelectric(ME)effect of ring-shaped com-posites,in which stress boundary conditions are empoyed and the multi-field coupling property of giant magnetostrictive materials are taken into
目的 探讨高龄老年髋部骨折患者围手术期并发症发生的危险因素.方法 收集惠州市中心人民医院2017年1-12月收治的191例80岁以上老年髋部骨折患者的临床资料,根据围手术期是否发生并发症分为无并发症组(126例)和并发症组(65例).统计高龄老年髋骨骨折患者围手术期并发症发生率,比较不同人口学特征的两组患者并发症的发生情况,运用多因素logistic回归分析并发症发生的危险因素.结果 高龄老年髋部骨折患者围手术期并发症发生率为34.1％(65/191),其中肺部感染发生率为最高(16.8％).与无并发症组
目的:总结达芬奇机器人辅助下胰十二指肠切除术的手术配合经验.方法:回顾性分析2021年1月至2021年4月浙江大学医学院附属第一医院肝胆胰外科机器人辅助下胰十二指肠切除术患者38例.护理要点包括手术室精细化布局、手术室护士专业化培训、达芬奇机器人手术系统的管理、器械护士配合关键点、巡回护士配合关键点.结果:在38例机器人辅助下胰十二指肠切除术中,共发生4起机器故障报警,3例术中中转开腹手术,3例发生低体温,所有患者均未发生压力性损伤.结论:机器人辅助下胰十二指肠切除术手术时间长、手术步骤复杂,加强手术室护
近年研究表明,微小RNA(miRNA)可以影响细胞的增殖、分化、迁移以及凋亡等生物功能.其中,miR-370 是近年来研究比较深入的 miRNA 之一.它通过多种机制,参与动脉粥样硬化、糖尿病、肿瘤、脓毒症等多种老年常见病的发生发展.
利用生物底盘进行生物农药的绿色低耗能生产是合成生物学未来发展的重要方向.除虫菊酯是一种源自菊科植物除虫菊的天然高效杀虫剂,具有广谱和强力的杀虫和驱虫作用,相较于化学合成的类似物(拟除虫菊酯),对哺乳动物毒性小,无环境危害,是生物农药的最优选择之一,具有广阔的应用前景.天然除虫菊酯含有六种主要成分,由两种异型萜类酸配体和茉莉酸合成途径来源的三种醇配体缩合而成.本文总结了除虫菊酯的研究历程,重点介绍了其生物合成途径解析与生物制造等方面的进展,综述了近期解析的细胞色素P450等相关生物合成酶,并讨论除虫菊酯生产
光作为诱导因子具有响应速度快、无损、可逆和独特的时空特异性等优势,已广泛应用于生物底盘细胞的工程化改造中.本研究构建重组解脂耶氏酵母(Yarrowia lipolytica)的光控表达系统,成功实现了对香豆酸和柚皮素合成.该光控系统基于绿光响应调控因子CarH以及转录激活因子VPR-HSF1,构建了光响应复合体CarH-VPRH,而该复合体在绿光照射条件下无法聚合,从而不能调控目标基因的转录与表达.结果表明,基于光控因子CarH-VPRH、诱导型启动子2CarOTEF以及报告基因mCherry构建的光诱导
目的:对比接受达芬奇机器人辅助下胸腔镜手术和常规胸腔镜手术的肺癌患者在围手术期康复效果的差异.在达芬奇肺癌日间流程以及肺癌患者围手术期进行加速康复外科实践并观察其对患者康复效果的影响.方法:选取2021年1月至2021年4月浙江大学医学院附属第二医院滨江院区施行的各类达芬奇机器人辅助下胸腔镜肺叶、肺段、肺袖式切除治疗的肺癌患者99例(达芬奇组),与本医疗组同时期进行单孔胸腔镜肺癌根治术的患者256例(常规胸腔镜组),对两组患者的平均住院日、疼痛评分、术后漏气延迟拔管等临床资料进行对比.两组患者均符合本院医